Breaking News Instant updates and real-time market news.

TJX

TJX

$52.95

-0.08 (-0.15%)

, HD

Home Depot

$190.87

-1.66 (-0.86%)

20:25
05/20/19
05/20
20:25
05/20/19
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Home Depot (HD), consensus $2.19... TJX Companies (TJX), consensus 55c... AutoZone (AZO), consensus $15.14... Kohl's (KSS), consensus 67c... Eaton Vance (EV), consensus 75c... J. C. Penney (JCP), consensus (38c).

TJX

TJX

$52.95

-0.08 (-0.15%)

HD

Home Depot

$190.87

-1.66 (-0.86%)

AZO

AutoZone

$978.78

-5.21 (-0.53%)

KSS

Kohl's

$62.95

-0.68 (-1.07%)

EV

Eaton Vance

$37.27

-0.535 (-1.42%)

JCP

J.C. Penney

$1.15

0.01 (0.88%)

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 23

    May

  • 24

    May

  • 29

    May

  • 04

    Jun

  • 11

    Jun

TJX TJX
$52.95

-0.08 (-0.15%)

04/11/19
ARGS
04/11/19
NO CHANGE
Target $62
ARGS
Buy
TJX price target raised to $62 from $55 at Argus
Argus analyst Chris Graja raised his price target on TJX to $62 and kept his Buy rating, citing the company's "exceptional financial strength, efficient cost structure, and ability to deliver value-priced merchandise in a competitive retail environment." The analyst also points to TJX's 22 consecutive years of comps increases with only one year of decline in all of its 42-year history, its growing store traffic, and its 23 straight years of rising dividends. Graja adds that while retail is pressured by the internet competition, the "off-price" sector is the industry's strongest segment, with TJX being "better positioned to compete than most" retailers.
05/13/19
BARD
05/13/19
INITIATION
Target $63
BARD
Outperform
TJX initiated with an Outperform at Baird
Baird analyst Mark Altschwager initiated TJX with an Outperform and $63 price target.
05/14/19
BARD
05/14/19
INITIATION
Target $63
BARD
Outperform
TJX initiated with an Outperform at Baird
Baird analyst Mark Altschwager initiated TJX with an Outperform rating and $63 price target, saying he thinks TJX can sustain at least mid single digit-high single digit EPS growth long-term supported by low single digit-mid single digit comps, unit growth and "steady" buybacks.
05/14/19
05/14/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. MannKind (MNKD) initiated with a Buy, $3 price target at BTIG. 2. Ross Stores (ROST) and TJX (TJX) initiated with an Outperform at Baird. 3. Elastic (ESTC) initiated with a Hold at Stifel. 4. CytomX Therapeutics (CTMX) initiated with an Overweight at Cantor Fitzgerald. 5. FIS (FIS) initiated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
HD Home Depot
$190.87

-1.66 (-0.86%)

04/25/19
BARD
04/25/19
NO CHANGE
Target $220
BARD
Outperform
Baird boosts Home Depot, Lowe's price targets after 'positive' checks
Baird analyst Peter Benedict is "increasingly comfortable" with Q1 comp expectations for Home Depot (HD) and Lowe's (LOW) after his firm's channel checks on early spring seasonal demand have been "positive." Further, broader indicators of industry sales suggest improved trends as Q1 progressed, Benedict tells investors in a research note. While some consolidation of recent share gains is possible near-term, investors should stay involved with macro demand drivers improving, says Benedict. He raised his price target for Home Depot to $220 from $200 and for Lowe's to $133 from $126. The analyst keeps Outperform ratings on both names.
05/02/19
WELS
05/02/19
NO CHANGE
Target $215
WELS
Outperform
Home Depot price target raised to $215 from $205 at Wells Fargo
Wells Fargo analyst Zachary Fadem raised his price target for Home Depot to $215 from $205 after hosting investor meetings with the company's Regional Vice President Dave Rebtoy and members of the Investor Relations team. The analyst notes that choppy Q1 weather should not be a surprise at this point, but Home Depot appears confident that the bathtub effect holds in 1H, with anticipated comp acceleration in the second half of the year. Fadem also believes the company's playbook will improve Pro penetration, store productivity and expanding fulfillment options is making notable progress, and while the retirement of long time CFO Carol Tome marks the end of an era, successor Richard McPhail has been long viewed as the obvious internal choice. He reiterates an Outperform rating on the shares.
05/07/19
RBCM
05/07/19
NO CHANGE
RBCM
Outperform
Home Depot, Lowe's price targets lowered at RBC Capital
RBC Capital analyst Scot Ciccarelli lowers his price targets on Buy-rated Home Depot (HD) to $217 from $223 and Lowe's (LOW) to $120 from $124 to reflect the adverse weather related impact as well as moderating macro trends. The analyst cites moderation in home price growth and Private Fixed Residential Investment trends, warning that while some home sales will be pushed into Q2, the comparable in the quarter from last year is "sizable." Ciccarelli adds that after nearly a decade of outperformance, earnings growth rates of 15%-20% for the home improvement industry may be over.
05/07/19
JPMS
05/07/19
NO CHANGE
JPMS
JPMorgan lowers Q1 comp estimates for Home Depot and Lowe's
To reflect "not-so-cooperative" weather and a softer backdrop following his firm's annual Spring tours, JPMorgan analyst Christopher Horvers lowered his U.S. Q1 comp estimate for Home Depot (HD) to 3.7% from 4.0% and for Lowe's to 2.7% from 3.2%. The analyst keeps an Overweight rating on Home Depot with a $203 price target and Neutral rating on Lowe's with a $104 price target.
AZO AutoZone
$978.78

-5.21 (-0.53%)

04/17/19
UBSW
04/17/19
NO CHANGE
Target $470
UBSW
Buy
O'Reilly Automotive, AutoZone price targets increased at UBS
UBS analyst Michael Lasser raised the price targets on his Buy-rated O'Reilly Automotive (ORLY) and AutoZone (AZO) to $470 and $1,210 from $415 and $1,065 respectively as part of his broader research note on auto repair shops. The analyst cites the findings of his bi-annual survey gauging sector demand, saying that some 69% of the shops surveyed saw sales volume as "at least flat" in March vs. the 66% who reported those figures last year. Lassar adds that while Q1 decelerated to 38% from 46%, about a third of the shops surveyed indicated that adverse weather hurt their business trends and the quarter was not indicative of the overall demand.
04/15/19
JPMS
04/15/19
NO CHANGE
Target $1126
JPMS
Overweight
AutoZone price target raised to $1,126 from $995 at JPMorgan
JPMorgan analyst Christopher Horvers raised his price target for AutoZone to $1,126 from $995 after hosting meetings with management. The company remains optimistic about sustained opportunities to grow its commercial program productivity toward the level of peers, Horvers tells investors in a research note. The analyst believes momentum in the sector remains intact and he expects AutoZone to have a strong finish to its current quarter. He keeps an Overweight rating on the shares.
04/01/19
SBSH
04/01/19
UPGRADE
Target $18
SBSH
Neutral
Bed Bath & Beyond upgraded to Neutral from Sell at Citi
Citi analyst Geoff Small upgraded Bed Bath & Beyond (BBBY) to Neutral from Sell and raised his price target for the shares to $18 from $10 after taking over coverage of the name. Citi transferred coverage of Broadlines & Hardlines Retail names to Small. The analyst assumed coverage with Buy ratings on AutoZone (AZO), BJ's Wholesale (BJ), Home Depot (HD), Lowe's (LOW), O'Reilly Automotive (ORLY) and Walmart (WMT). The U.S. consumer remains on "solid footing" amid low unemployment, rising wages, declining gas prices, manageable levels of debt, and elevated consumer confidence, Small tells investors in a research note. However, he points out that we are in the ninth year of the current economic expansion and "the possibility of a macroeconomic slowdown cannot be ignored." The analyst prefers retailers operating in "defensive sectors that are less susceptible to disruption by online competitors," namely auto parts, broadlines and home improvement retail. Small also assumed Advance Auto Parts (AAP), Best Buy (BBY), Costco (COST) and Office Depot (ODP) with Neutral ratings.
04/23/19
FBCO
04/23/19
NO CHANGE
Target $1131
FBCO
Outperform
AutoZone price target raised to $1,131 from $1,050 at Credit Suisse
Credit Suisse analyst Seth Sigman raised his price target for AutoZone to $1,131 from $1,050 after hosting meetings with the company's management. The analyst notes that the team provided a positive view on the sector outlook, as well as the prospects for its commercial business based on a number of changes made over the last couple of years and the potential for less incremental expense growth in the out years after the step-up this year. Overall, Sigman came away confident in the company's ability to sustain recent sales/gross margin momentum, which combined with its discount valuation should support further outperformance. He reiterates an Outperform rating on the shares.
KSS Kohl's
$62.95

-0.68 (-1.07%)

04/23/19
BARD
04/23/19
NO CHANGE
Target $85
BARD
Outperform
Kohl's, Amazon expanded partnership suggests successful pilot, says Baird
Baird analyst Mark Altschwager noted that Kohl's (KSS) are up over 8% on the news that it will Kohl's expand the Amazon Returns program to all stores nationwide along with an agreement to issue warrants to Amazon to purchase up to ~1.75M shares of Kohl's over the next five years. Altschwager tells investors in a research note that he expects more details on the Q1 call but the expanded relationship suggests the returns pilot has been successful and gives him increased confidence in Kohl's ability to drive traffic growth in the periods ahead. The analyst maintains an Outperform rating and $85 price target on Kohl's.
03/06/19
ATLE
03/06/19
UPGRADE
ATLE
Neutral
Kohl's upgraded to Neutral from Underweight at Atlantic Equities
03/06/19
COWN
03/06/19
NO CHANGE
Target $82
COWN
Outperform
Kohl's remains top department store pick, says Cowen
Cowen analyst Oliver Chen said he was encouraged by Kohl's' (KSS) numerous initiatives and tests to drive continued comp momentum in 2019. He likes the strategy to lean further into active lifestyle, especially its partnering with Planet Fitness (PLNT) to build gyms next to Kohl's stores. Chen reiterated his Outperform rating and $82 price target and said Kohl's remains his top department store pick.
03/06/19
03/06/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Kohl's (KSS) upgraded to Neutral from Underweight at Atlantic Equities. 2. Volaris (VLRS) double upgraded to Buy from Sell at Goldman Sachs. 3. Mylan (MYL) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst David Risinger saying he believes the stock "can finally outperform" for the remainder of 2019 following a substantial reset that has the shares trading near the bottom end of their historical range of the past five years and at a historical discount to peers. 4. PNC Financial (PNC) upgraded to Outperform from Neutral at Macquarie with analyst David Konrad citing recent multiple compression, high BlackRock estimates and potential regulatory change for capital deductions. 5. Ambarella (AMBA) upgraded to Buy from Hold at Craig-Hallum with analyst Richard Shannon saying he sees sales inflection coming in the second half, and as multiple indicators suggest growth in auto and security, supported by computer vision-enabled products. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
EV Eaton Vance
$37.27

-0.535 (-1.42%)

05/20/19
BOFA
05/20/19
DOWNGRADE
BOFA
Underperform
Eaton Vance downgraded to Underperform from Buy at BofA/Merrill
05/20/19
BOFA
05/20/19
DOWNGRADE
Target $37
BOFA
Underperform
Eaton Vance downgraded to Underperform on weaker growth at BofA/Merrill
As previously reported, BofA/Merrill double downgraded Eaton Vance to Underperform from Buy and cut its price target to $37 from $45. Analyst Michael Carrier lowered estimates to reflect slower flow trends, a difficult product mix, and potential margin pressures ahead. Carrier expects higher fee floating rate and alternative products to experience outflows given weak performance and macro trends.
05/20/19
05/20/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. American Airlines (AAL) downgraded to Underweight from Equal Weight at Morgan Stanley while Delta Air Lines (DAL) was downgraded to Equal Weight from Overweight. 2. Deutsche Bank (DB) downgraded to Sell from Neutral at UBS with the firm saying the bank is facing limited strategic options and its operating conditions are unlikely to improve in the near term amid intense competition. 3. Eaton Vance (EV) double downgraded to Underperform from Buy at BofA/Merrill with analyst Michael Carrier lowering estimates to reflect slower flow trends, a difficult product mix, and potential margin pressures ahead. 4. ProAssurance (PRA) downgraded to Underperform from Market Perform at Keefe Bruyette with analyst Christopher Campbell saying the stock has rallied 9% since the company's "disappointing" Q1 results. 5. Clorox (CLX) downgraded to Hold from Buy at Argus with analyst John Staszak citing the company's revenue deceleration reported in Q3 to "just 2%" as well as its near-term growth outlook cut to 2%-3% from 2%-4%. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/14/19
FBCO
01/14/19
NO CHANGE
Target $43
FBCO
Neutral
Eaton Vance price target lowered to $43 from $51 at Credit Suisse
Credit Suisse analyst Ari Ghosh lowered his price target for Eaton Vance to $43 from $51 ahead of quarterly results. The analyst reiterates a Neutral rating on the shares.
JCP J.C. Penney
$1.15

0.01 (0.88%)

11/16/18
ARGS
11/16/18
DOWNGRADE
ARGS
Sell
J.C. Penney downgraded to Sell from Hold at Argus
Argus analyst John Eade downgraded J.C. Penney to Sell, anticipating continued losses for the stock for the next two years while also warning that at a current share price below $2, the company is operating with a more elevated risk. The analyst states that while J.C Penney has made efforts to "restructure its merchandise assortment, close underperforming stores, and bolster its Omnichannel business, its operating results continue to deteriorate." Eade cites the company's margin deterioration coming from store closings, poor inventory management, and "steep discounting" intended to clear excess inventory. The analyst also sees J.C. Penney operating against "intense" competition from a wide range of retailers and suffering from weak mall traffic, while also facing a very expensive "arms race" to improve e-commerce capabilities.
01/16/19
FBCO
01/16/19
NO CHANGE
Target $50
FBCO
Neutral
Nordstrom price target lowered to $50 from $55 at Credit Suisse
Credit Suisse analyst Michael Binetti lowered his price target for Nordstrom (JWN) to $50 from $55 on weak full-price holiday adding to already clearance filled January. With Nordstrom adding to industry markdown issues, the analyst sees negative reads for J.C. Penney (JCP), Kohl's (KSS), Gap (GPS), but positive for Burlington Stores (BURL), Ross Stores (ROST), and TJX (TJX). Binetti reiterates a Neutral rating on Nordstrom shares.
01/09/19
FBCO
01/09/19
NO CHANGE
FBCO
J.C. Penney looks best positioned to gain share from Sears, says Credit Suisse
Looking at potential near-term same-store sales lift Softlines Retail peers could see from share gains based on proximity to Sears (SHLD) stores amid a possible liquidation, Credit Suisse analyst Michael Binetti says J.C. Penney (JCP) and Burlington Stores (BURL) seem best positioned to gain share in 2019 due to close proximity. And while J.C. Penney looks best positioned to gain share from Sears, the analyst thinks the recent stock run-up is "a short-term bounce." Binetti does not see this as sustainable customer acquisition for J.C. Penney given the increased risk of closing destabilized malls, limited visibility to an improved merchandise strategy, and leverage constraints to growth investing. Overall, the analyst believes that while there may be some near-term share benefit, a Sears liquidation could be a bigger tipping point that will accelerate closures of already weakening U.S. C&D malls.
11/16/18
11/16/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Home Depot (HD) downgraded to Neutral from Buy at BofA/Merrill with analyst Elizabeth Suzuki saying peak growth has passed. 2. J.C. Penney (JCP) downgraded to Sell from Hold at Argus with analyst John Eade saying he anticipates continued losses for the stock for the next two years while also warning that at a current share price below $2, the company is operating with a more elevated risk. 3. Nvidia (NVDA) was downgraded to Neutral from Buy at B. Riley FBR and to Buy from Conviction Buy at Goldman Sachs. 4. Michael Kors (KORS) downgraded to Perform from Outperform at Oppenheimer with analyst Brian Nagel saying he is "concerned" that ongoing challenges with inventory management and replenishment at the company's namesake brand and softness within fashion watches will weigh on top-line trends and potentially margins, just as management begins the integration of Versace. 5. TSMC (TSM) was downgraded to Equal Weight from Overweight at Morgan Stanley while UMC (UMC) was downgraded to Underweight from Equal Weight. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ALDX

Aldeyra

$7.08

-0.29 (-3.93%)

07:33
06/25/19
06/25
07:33
06/25/19
07:33
Conference/Events
Aldeyra to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMX

BioPharmX

$0.85

-0.0563 (-6.22%)

07:31
06/25/19
06/25
07:31
06/25/19
07:31
Hot Stocks
BioPharmX announces results from Phase 2b clinical trial of BPX-041 »

BioPharmX announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

MEET

Meet Group

$3.31

-0.265 (-7.42%)

, AAPL

Apple

$198.60

-0.17 (-0.09%)

07:31
06/25/19
06/25
07:31
06/25/19
07:31
Recommendations
Meet Group, Apple, Alphabet, Alphabet Class A analyst commentary  »

Meet Group should be able…

MEET

Meet Group

$3.31

-0.265 (-7.42%)

AAPL

Apple

$198.60

-0.17 (-0.09%)

GOOG

Alphabet

$1,115.75

-6.63 (-0.59%)

GOOGL

Alphabet Class A

$1,117.00

-8.17 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 25

    Jul

  • 25

    Jul

  • 27

    Oct

AKRX

Akorn

$4.71

-0.06 (-1.26%)

07:30
06/25/19
06/25
07:30
06/25/19
07:30
Hot Stocks
Breaking Hot Stocks news story on Akorn »

Akorn trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$41.15

11.87 (40.54%)

07:30
06/25/19
06/25
07:30
06/25/19
07:30
Recommendations
Krystal Biotech analyst commentary  »

Krystal Biotech price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

ETFC

E-Trade

$44.57

-1.66 (-3.59%)

07:30
06/25/19
06/25
07:30
06/25/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

ALDX

Aldeyra

$7.08

-0.29 (-3.93%)

07:30
06/25/19
06/25
07:30
06/25/19
07:30
Hot Stocks
Breaking Hot Stocks news story on Aldeyra 

Aldeyra trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$30.51

-0.98 (-3.11%)

07:26
06/25/19
06/25
07:26
06/25/19
07:26
Periodicals
Buffett denies reports of tension between him, 3G over Kraft Heinz, CNBC reports »

Buffett says 3G's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$223.66

1.76 (0.79%)

07:26
06/25/19
06/25
07:26
06/25/19
07:26
Recommendations
Tesla analyst commentary  »

Oppenheimer continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRUB

GrubHub

$72.05

0.91 (1.28%)

, MCD

McDonald's

$203.92

-0.29 (-0.14%)

07:26
06/25/19
06/25
07:26
06/25/19
07:26
Upgrade
GrubHub, McDonald's, Starbucks rating change  »

Citi sees five reasons to…

GRUB

GrubHub

$72.05

0.91 (1.28%)

MCD

McDonald's

$203.92

-0.29 (-0.14%)

SBUX

Starbucks

$83.65

-0.16 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 09

    Jul

  • 26

    Jul

ERI

Eldorado Resorts

$45.86

-5.36 (-10.46%)

07:25
06/25/19
06/25
07:25
06/25/19
07:25
Conference/Events
Eldorado Resorts to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

BPOP

Popular

$52.70

0.37 (0.71%)

07:23
06/25/19
06/25
07:23
06/25/19
07:23
Recommendations
Popular analyst commentary  »

Popular's valuation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

MYGN

Myriad Genetics

$23.04

-0.47 (-2.00%)

07:23
06/25/19
06/25
07:23
06/25/19
07:23
Hot Stocks
Myriad Genetics announces publication of EndoPredict cost effectiveness study »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 06

    Aug

  • 13

    Nov

HEXO

HEXO Corp

$5.35

-0.245 (-4.38%)

07:20
06/25/19
06/25
07:20
06/25/19
07:20
Downgrade
HEXO Corp rating change  »

HEXO Corp downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVXL

Anavex

$3.25

-0.12 (-3.56%)

07:20
06/25/19
06/25
07:20
06/25/19
07:20
Hot Stocks
Anavex announces first patient dosed in Rett syndrome extension study »

Anavex announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANGI

Angi Homeservices

$14.38

-0.21 (-1.44%)

07:19
06/25/19
06/25
07:19
06/25/19
07:19
Recommendations
Angi Homeservices analyst commentary  »

Angi Homeservices price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

BHF

Brighthouse Financial

$38.10

-0.01 (-0.03%)

07:19
06/25/19
06/25
07:19
06/25/19
07:19
Downgrade
Brighthouse Financial rating change  »

Brighthouse Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGTC

Applied Genetic

$3.80

-0.145 (-3.68%)

, AERI

Aerie Pharmaceuticals

$30.21

-0.7 (-2.26%)

07:18
06/25/19
06/25
07:18
06/25/19
07:18
Hot Stocks
Applied Genetic names Theresa Heah CMO, Brian Krex general counsel »

Applied Genetic (AGTC)…

AGTC

Applied Genetic

$3.80

-0.145 (-3.68%)

AERI

Aerie Pharmaceuticals

$30.21

-0.7 (-2.26%)

ALXN

Alexion

$126.92

-5.55 (-4.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 10

    Jul

  • 11

    Jul

  • 31

    Jul

  • 01

    Aug

MCHP

Microchip

$85.16

0.08 (0.09%)

07:16
06/25/19
06/25
07:16
06/25/19
07:16
Initiation
Microchip initiated  »

Microchip initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLAB

Silicon Labs

$96.26

-0.41 (-0.42%)

07:14
06/25/19
06/25
07:14
06/25/19
07:14
Initiation
Silicon Labs initiated  »

Silicon Labs initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNC

Lincoln National

07:14
06/25/19
06/25
07:14
06/25/19
07:14
Upgrade
Lincoln National rating change  »

Lincoln National upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

TRI

Thomson Reuters

$65.83

-0.16 (-0.24%)

07:13
06/25/19
06/25
07:13
06/25/19
07:13
Downgrade
Thomson Reuters rating change  »

Thomson Reuters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$39.80

-1.26 (-3.07%)

07:13
06/25/19
06/25
07:13
06/25/19
07:13
Recommendations
Biohaven Pharmaceutical analyst commentary  »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

SHW

Sherwin-Williams

$465.88

0.225 (0.05%)

07:13
06/25/19
06/25
07:13
06/25/19
07:13
Downgrade
Sherwin-Williams rating change  »

Sherwin-Williams…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 11

    Jul

ARVN

Arvinas

$21.81

(0.00%)

07:12
06/25/19
06/25
07:12
06/25/19
07:12
Hot Stocks
Arvinas announces FDA clearance of ARV-471 IND »

Arvinas announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.